ContractXtant Medical Holdings, Inc. • January 20th, 2017 • Biological products, (no disgnostic substances) • New York
Company FiledJanuary 20th, 2017 Industry JurisdictionTHE SALE OF THIS NOTE HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, THIS NOTE (AND ANY BENEFICIAL INTEREST HEREIN) MAY NOT BE OFFERED, RESOLD OR OTHERWISE TRANSFERRED, EXCEPT:
ContractXtant Medical Holdings, Inc. • January 20th, 2017 • Biological products, (no disgnostic substances) • New York
Company FiledJanuary 20th, 2017 Industry JurisdictionTHE SALE OF THIS NOTE HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, THIS NOTE (AND ANY BENEFICIAL INTEREST HEREIN) MAY NOT BE OFFERED, RESOLD OR OTHERWISE TRANSFERRED, EXCEPT:
ContractXtant Medical Holdings, Inc. • January 20th, 2017 • Biological products, (no disgnostic substances) • New York
Company FiledJanuary 20th, 2017 Industry JurisdictionTHE SALE OF THIS NOTE HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, THIS NOTE (AND ANY BENEFICIAL INTEREST HEREIN) MAY NOT BE OFFERED, RESOLD OR OTHERWISE TRANSFERRED, EXCEPT:
ContractXtant Medical Holdings, Inc. • January 20th, 2017 • Biological products, (no disgnostic substances) • New York
Company FiledJanuary 20th, 2017 Industry JurisdictionTHE SALE OF THIS NOTE HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, THIS NOTE (AND ANY BENEFICIAL INTEREST HEREIN) MAY NOT BE OFFERED, RESOLD OR OTHERWISE TRANSFERRED, EXCEPT: